Clinical Trial Update: N-Acetylcysteine Protection Against Radiation Induced Cellular Damage [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating N-Acetylcysteine for protection against radiation-induced cellular damage in patients with Cardiac Arrhythmia; the study status is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrhythmia

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Centro Cardiologico Monzino | Conditions: Cardiac Arrhythmia | Phase 2 | Status: COMPLETED